Health
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial – The Lancet
Consistent with international society recommendations, renin–angiotensin system inhibitorscan be safely continued in patients admitted to hospital with COVID-19….
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
Copyright © 2021 Elsevier Inc. except certain content provided by third parties.
Privacy Policy Terms and Conditions
Continue Reading
-
Business15 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business11 hours agoDicker Data rides the AI trend to double digit growth
-
Business19 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Noosa News19 hours agoOld Translink app canned, and new version ‘worse than paper map from 2015’